Centessa Pharmaceuticals plc - American Depositary Shares — Cash Flow (NASDAQ:CNTA) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -769 K-200.55 M-160.34 M-142.06 M-193.82 M -193.82 M Cash from investing activities 0-931 K-127 M31.27 M-418.53 M -418.53 M Cash from financing activities 1.36 M457 K21.12 M364.75 M291.53 M 291.53 M Free cash flow -769 K-201.68 M-160.51 M-142.09 M-194.19 M -194.06 M

뉴스

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal

Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket

Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

울프 리서치, 센테사 주식에 대해 시장수익률 상회 등급으로 시작

Wolfe Research initiates Centessa stock with outperform rating

파이퍼 샌들러, 센테사 주식에 ’비중확대’ 의견 재확인

Piper Sandler reiterates Overweight rating on Centessa stock ahead of catalysts

센테사, 동물 실험서 OX2R 작용제의 항우울 효과 보고

Centessa reports antidepressive effects of OX2R agonist in animal study

센테사 제약, 주가 하락은 매수 기회 - TD Cowen

Centessa Pharmaceuticals stock pullback offers good entry point, says TD Cowen